Abstract
-Blocker Effects on SQTS-Mutant K+ Channels BackgroundN588K-KCNH2 and V307L-KCNQ1 mutations lead to a gain-of-function of I-Kr and I-Ks thus causing short-QT syndromes (SQT1, SQT2). Combined pharmacotherapies using K+-channel-blockers and -blockers are ef
| Original language | English |
|---|---|
| Pages (from-to) | 1163-1171 |
| Number of pages | 9 |
| Journal | Journal of Cardiovascular Electrophysiology |
| Volume | 24 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - Oct 2013 |
Keywords
- beta-adrenergic blocker
- carvedilol
- metoprolol
- potassium current
- short-QT syndrome
Fingerprint
Dive into the research topics of 'Differential Effects of the beta-Adrenoceptor Blockers Carvedilol and Metoprolol on SQT1-and SQT2-Mutant Channels'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver